Neurocrine Bio. (NBIX) PT Lowered to $163 at Guggenheim
Tweet Send to a Friend
(Updated - February 10, 2025 7:28 AM EST)
Guggenheim analyst Yatin Suneja lowered the price target on Neurocrine Bio ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Guggenheim analyst Yatin Suneja lowered the price target on Neurocrine Bio ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
